Understanding Liraglutide and Its Impact Liraglutide, a GLP-1 receptor agonist, has been a cornerstone in the treatment of type 2 diabetes, helping to improve blood sugar control when used alongside diet and exercise
Peptides can be taken in various ways
When to contact your GP: Persistent severe nausea or vomiting that prevents adequate fluid intake Signs of dehydration (dizziness, dark urine, reduced urination) Severe abdominal pain that could indicate pancreatitis Symptoms of very low blood sugar (confusion, sweating, trembling) if taking other diabetes medications Blood pressure readings consistently below 90/60 mmHg or above your target range Blood pressure readings of 180/120 mmHg or higher, especially with symptoms such as severe headache, chest pain, or vision problems (seek same-day medical assessment) Any new or concerning symptoms Your healthcare team may adjust your blood pressure medications if your readings improve significantly
Typically, the dose is reduced gradually by 2550 mg every 48 weeks, with monitoring for any recurrence of acne or increased hair growth